CUSTODIOL HTK (Histidine-Tryptophan-Ketoglutarate) is indicated for preservation of multiorgan transplants (heart, kidney, liver, pancreas, lung), together with venous or arterial segments.

For complete prescribing information, please consult the Package Insert. For more information on CUSTODIOL, please click here.

CYANOKIT contains hydroxocobalamin, an antidote indicated for the treatment of known or suspected cyanide poisoning. Cyanokit is to be administered together with appropriate decontamination and supportive measures.

For complete prescribing information, please consult the Product Monograph. For more information on CYANOKIT, please click here.

Erythrocin I.V. (erythromycin lactobionate injection) is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in (1) Lower respiratory tract infections of mild to moderate severity caused by S. pyogenes (Group A beta-hemolytic streptococci), S. pneumoniae and M. pneumoniae; (2) Skin and soft tissue infections of mild to moderate severity caused by S. pyogenes and S. Aureus; and (3) Legionnaires’ disease caused by L. pneumophila.

For complete prescribing information, please consult the Product Monograph.

KENGREXAL (cangrelor) is indicated for reducing the risk of thrombotic cardiovascular events (periprocedural myocardial infarction (MI), repeat coronary revascularization, and stent thrombosis (ST)) in patients with coronary artery disease undergoing percutaneous coronary intervention who have not been treated with an oral P2Y12 platelet inhibitor and are not being given a glycoprotein IIb/IIIa inhibitor.

For complete prescribing information, please consult the Product Monograph.

Intramuscular injection of Toradol (ketorolac tromethamine) is indicated for:

• The short-term management (not to exceed 2 days) of moderate to severe acute pain, including pain following major abdominal, orthopaedic and gynaecological operative procedures.

For more information, please consult the Product Monograph.